Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Izokibep in Ankylosing Spondylitis
NCT04795141Phase 2Terminated
- Start
- Aug 2021
- Primary completion
- Jul 2022
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of izokibep in ankylosing spondylitis (AS). Started Aug 2021; status: terminated.
02
Drugs
izokibep
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT04795141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04795141.